TELO Stock Summary and Trading Ideas (Telomir Pharmaceuticals | NASDAQ:TELO)

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Telomir Pharmaceuticals trades on the NASDAQ stock market under the symbol TELO.

As of July 7, 2026, TELO stock price declined to $1.24 with 41,749 million shares trading.

TELO has a beta of 1.06, meaning it tends to be more sensitive to market movements. TELO has a correlation of 0.02 to the broad based SPY ETF.

TELO has a market cap of $85.28 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that TELO belongs to (by Net Assets): VTI, VXF, IWC.

TELO has underperformed the market in the last year with a price return of +7.8% while the SPY ETF gained +20.8%. TELO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.6% and -3.1%, respectively, while the SPY returned +13.8% and +0.4%, respectively.

TELO support price is $1.22 and resistance is $1.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TELO shares will trade within this expected range on the day.